Efficacy of salvage radiotherapy for relapsed/refractory diffuse large B-cell lymphoma

por Wang, Shu-Bei, Chen, Jia-Yi, Zhao, Wei-Li, Kirova, Youlia M., Cao, Wei-Guo
Publicado 2019

Identification of patients with locally advanced rectal cancer eligible for neoadjuvant chemotherapy alone: Results of a retrospective study

por Han, Yi‐min, Qi, Wei‐xiang, Wang, Shu‐bei, Cao, Wei‐guo, Chen, Jia‐yi, Cai, Gang
Publicado 2023

Evaluation of systemic inflammatory and nutritional indexes in locally advanced gastric cancer treated with adjuvant chemoradiotherapy after D2 dissection

por Wang, Shu-Bei, Chen, Jia-Yi, Xu, Cheng, Cao, Wei-Guo, Cai, Rong, Cao, Lu, Cai, Gang
Publicado 2022

Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy

por Xu, Fei-Fei, Cao, Lu, Xu, Cheng, Cai, Gang, Wang, Shu-Bei, Qi, Wei-Xiang, Chen, Jia-Yi
Publicado 2022

Identification of Patients With Locally Advanced Gastric Cancer Who May Benefit From Adjuvant Chemoradiotherapy After D2 dissection: A Propensity Score Matching Analysis

por Wang, Shu-Bei, Qi, Wei-Xiang, Chen, Jia-Yi, Xu, Cheng, Cao, Wei-Guo, Cai, Rong, Cao, Lu, Cai, Gang
Publicado 2021

How Does the Interval Between Completion of Adjuvant Chemotherapy and Initiation of Radiotherapy Impact Clinical Outcomes in Operable Breast Cancer Patients?

por Cao, Lu, Xu, Cheng, Cai, Gang, Qi, Wei-Xiang, Cai, Rong, Wang, Shu-Bei, Ou, Dan, Li, Min, Shen, Kun-Wei, Chen, Jia-Yi
Publicado 2020

Prognostic and predictive significance of tumor infiltrating lymphocytes for ductal carcinoma in situ

por Xu, Fei-Fei, Zheng, Sai-Fang, Xu, Cheng, Cai, Gang, Wang, Shu-Bei, Qi, Wei-Xiang, Wang, Chao-Fu, Chen, Jia-Yi, Lu, Cao
Publicado 2021

Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy

por Wang, Shu-Bei, Qi, Wei-Xiang, Chen, Jia-Yi, Xu, Cheng, Kirova, Youlia M., Cao, Wei-Guo, Cai, Rong, Cao, Lu, Yan, Min, Cai, Gang
Publicado 2019

Influence of Adjuvant Radiotherapy Timing on Survival Outcomes in High-Risk Patients Receiving Neoadjuvant Treatments

por Cao, Lu, Xu, Cheng, Wang, Meng-Di, Qi, Wei-Xiang, Cai, Gang, Cai, Rong, Wang, Shu-Bei, Ou, Dan, Li, Min, Shen, Kun-Wei, Chen, Jia-Yi
Publicado 2022